Changes in primidone/phenobarbitone ratio during pregnancy and the puerperium. 1984

D Battino, and S Binelli, and L Bossi, and M L Como, and D Croci, and C Cusi, and G Avanzini

Plasma concentrations of primidone and its metabolite phenobarbitone were monitored in 9 pregnant epileptic patients treated with primidone (and in 3 cases other antiepileptic drugs) given at constant doses throughout pregnancy and the puerperium. Phenobarbitone plasma concentrations were monitored in another 6 patients given phenobarbitone itself. A trend towards increasing primidone plasma concentrations during the second quarter of pregnancy was evident in all patients, with a concomitant significant decrease in primidone-derived phenobarbitone plasma concentrations. A trend towards a lowering of plasma concentrations of phenobarbitone administered as such was confirmed. These results suggest the usefulness of a careful monitoring of primidone and primadone-derived phenobarbitone during pregnancy and the puerperium. Discrepancies of findings with primidone and phenobarbitone are discussed in view of the possible mechanism involved.

UI MeSH Term Description Entries
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D011324 Primidone A barbiturate derivative that acts as a GABA modulator and anti-epileptic agent. It is partly metabolized to PHENOBARBITAL in the body and owes some of its actions to this metabolite. Desoxyphenobarbital,Primaclone,Apo-Primidone,Liskantin,Misodine,Mizodin,Mylepsinum,Mysoline,Primidon Holsten,Resimatil,Sertan,Apo Primidone
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

D Battino, and S Binelli, and L Bossi, and M L Como, and D Croci, and C Cusi, and G Avanzini
August 2008, Therapeutic drug monitoring,
D Battino, and S Binelli, and L Bossi, and M L Como, and D Croci, and C Cusi, and G Avanzini
May 1964, The Journal of the American Osteopathic Association,
D Battino, and S Binelli, and L Bossi, and M L Como, and D Croci, and C Cusi, and G Avanzini
January 1968, The Journal of pharmacy and pharmacology,
D Battino, and S Binelli, and L Bossi, and M L Como, and D Croci, and C Cusi, and G Avanzini
January 1981, Bollettino della Societa italiana di cardiologia,
D Battino, and S Binelli, and L Bossi, and M L Como, and D Croci, and C Cusi, and G Avanzini
September 1981, Wiadomosci lekarskie (Warsaw, Poland : 1960),
D Battino, and S Binelli, and L Bossi, and M L Como, and D Croci, and C Cusi, and G Avanzini
April 2000, Journal of Korean medical science,
D Battino, and S Binelli, and L Bossi, and M L Como, and D Croci, and C Cusi, and G Avanzini
February 1981, Journal of neurology, neurosurgery, and psychiatry,
D Battino, and S Binelli, and L Bossi, and M L Como, and D Croci, and C Cusi, and G Avanzini
January 1995, Clinical and experimental obstetrics & gynecology,
D Battino, and S Binelli, and L Bossi, and M L Como, and D Croci, and C Cusi, and G Avanzini
June 1966, Nihon Sanka Fujinka Gakkai zasshi,
D Battino, and S Binelli, and L Bossi, and M L Como, and D Croci, and C Cusi, and G Avanzini
July 1969, Minerva ginecologica,
Copied contents to your clipboard!